About
Genetic 'Surgery' Therapeutics
Areas of Focus
Categories
NJ, NY, PA
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
173
By Phase
PHASE1/PHASE2: 2PHASE1: 4
By Status
RECRUITING: 2TERMINATED: 2WITHDRAWN: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05607420Lead Sponsor
Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma
PHASE1/PHASE2Recruiting
80 participants
Started: Nov 1, 2022 · Completed: Aug 31, 2027
NCT04142619Lead Sponsor
Study Evaluating Safety and Efficacy of UCART Targeting CS1 in Patients With Relapsed/Refractory Multiple Myeloma (MELANI-01)
PHASE1Terminated
11 participants
Started: Nov 21, 2019 · Completed: Jun 18, 2023
NCT04150497Lead Sponsor
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
PHASE1/PHASE2Recruiting
52 participants
Started: Oct 14, 2019 · Completed: Jun 30, 2026
NCT04106076Lead Sponsor
Phase I Study of UCART123 in Patient With Adverse Genetic Risk Acute Myeloid Leukemia
PHASE1Withdrawn
Started: Jul 11, 2019 · Completed: Dec 5, 2019
NCT03203369Lead Sponsor
Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN
PHASE1Terminated
1 participants
Started: Jun 28, 2017 · Completed: Jun 27, 2019
Locations (1)
Headquarters
New York, NY, United States
Map
Loading map...